Skip to content

The impact of vestibular dysfunction on insomnia and coping strategies

The impact of vestibular dysfunction on insomnia and coping strategies

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400085439
Enrollment
Unknown
Registered
2024-06-07
Start date
2024-01-20
Completion date
Unknown
Last updated
2024-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic insomnia

Interventions

Chronic insomnia patients (covert vestibular dysfunction):None

Sponsors

BEIJING LUHE HOSPITAL CAPITAL MEDICAL UNIVERSITY
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Meet the diagnostic criteria for chronic insomnia. Age =18 years and =80 years. Able to cooperate and complete vestibular function tests. The patient agrees to participate in this study and signs an informed consent form.

Exclusion criteria

Exclusion criteria: Have other physical illnesses or pain that can cause insomnia. Use of some psychotropic drugs that cause insomnia: antidepressants, central stimulants, cardiovascular drugs, bronchodilators, etc. history of severe alcohol or drug dependence or abuse. hift work or other types of self-imposed irregular sleep schedule. Daily intake of caffeine greater than 300mg (3-4 cups of coffee). Surgical diseases affecting posture and gait testing, or evident pain, muscle weakness due to osteoarthritis or rheumatoid arthritis. Cognitive impairment affecting the patient's understanding of tasks and instructions (Mini Mental State Examination =24). Concomitant acute coronary syndrome or severe arrhythmia, uncontrolled stability of lung, liver, kidney, and other organ diseases. With malignant tumors. Participation in another clinical trial (drug, medical device, or medical procedure research) within 30 days prior to study inclusion. Patients with insomnia due to anxiety or depression. Patients with insomnia and overt vestibular dysfunction.

Design outcomes

Primary

MeasureTime frame
the severity of vestibular dysfunction;the severity of insomnia;

Secondary

MeasureTime frame
The types and incidence of vestibular dysfunction;Basic information;

Countries

China

Contacts

Public ContactPan Gu

BEIJING LUHE HOSPITAL CAPITAL MEDICAL UNIVERSITY

607807@163.com+86 135 0115 3040

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026